Ron Finklestien
SEALSQ Corp Stock Soars 43% After Major Announcements
SEALSQ Corp Stock Soars 43% After Major Announcements
—
Turnaround for SEALSQ Corp SEALSQ Corp LAES shares traded higher on Tuesday. Over the past week, the stock has risen sharply after a prolonged ...
Delays in Boeing’s 737 MAX 10 Certification Could Halt Progress Until 2025
Delays in Boeing’s 737 MAX 10 Certification Could Halt Progress Until 2025
—
the_guitar_mann/iStock Editorial via Getty Images Boeing’s (NYSE:BA) struggle with the 737 MAX 10 certification may extend well beyond expectations, as revealed by Ryanair’s CEO ...
Financial Tidings: Stocks Aflame with Analyst Upgrades and Fresh Prognoses
—
As the financial market continues to whirl like a tempestuous sea, there is always a yearning for a lighthouse, a beacon to signal a ...
Exciting Developments in Gold Mining Industry
Exciting Developments in Gold Mining Industry
—
Top Stories for Jan. 16, 2024: 1. UBS Group initiated coverage on Alcoa Corporation AA with a Sell rating and price target of $29. ...
Article
The Rise and Fall of Medical Properties Trust
—
Analysis of Dividend Yield as an Investment Metric In this piece, we will dissect the roller-coaster journey of Medical Properties Trust (NYSE:MPW) stock to ...
Korean Banks Upgraded to Buy at BofA on Export Recovery
Korean Banks Upgraded to Buy at BofA on Export Recovery
—
TkKurikawa/iStock Editorial via Getty Images Bank of America analyst Jeehoon Park has made a bold move, upgrading Korean banks Shinhan Financial Group (NYSE:SHG) and ...
Uber Shuts Down Drizly
Uber Shuts Down Drizly
—
Uber Technologies has announced its decision to close its Alcohol Delivery Service, Drizly. This move by the ride-hailing company is aimed at refocusing on ...
Market Shifts: Stocks Poised for Success
Massive Shifts in the Market: Identifying Stocks Poised for Success
—
In 2023, the financial landscape was tumultuous, marked by the dominance of the “higher rates for longer” narrative and artificial intelligence hype. This turbulent ...
CRISPR/Vertex gene editing therapy approved in U.S. for beta-thalassemia
Breakthrough Gene-Editing Therapy Approved for Beta-Thalassemia Treatment
—
ipopba Finally, after intense anticipation, Vertex Pharmaceuticals (NASDAQ:VRTX) has triumphed as the U.S. FDA has granted its trailblazing gene editing therapy, Casgevy, developed in ...
Why Now Is the Time to Invest in Copa Holdings (CPA) Stock
Why Now Is the Time to Invest in Copa Holdings (CPA) Stock
—
Copa Holdings, S.A. CPA has proven its mettle in the past year and shows potential for continued success. If you haven’t already capitalized on ...
